NOVEL ASPECT OF NATURAL FLAVONOL FISETIN VIA INHIBITING ACSL4-MEDIATED TUBULAR FERROPTOSIS AGAINST FIBROTIC KIDNEY DISEASE

WCN23-1033
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine
 
 
 
 
NOVEL ASPECT OF NATURAL FLAVONOL FISETIN VIA INHIBITING ACSL4-MEDIATED TUBULAR FERROPTOSIS AGAINST FIBROTIC KIDNEY DISEASE
Yang, L.(1)*;Wang, B.(1);Ma, L.(1);Fu, P.(1);
ie: Azwin Z.1, Siti Y.1, John D.2
(1)Kidney Research Institute- Division Of Nephrology, West China Hospital Of Sichuan University, Chengdu, China;
 
 
if any